DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: TECFIDERA (dimethyl fumarate, BG-12, Fumaderm)
*****************************************************
#Post#: 3000--------------------------------------------------
(Abst.) PML in Tecfidera-treated MS patients
By: agate Date: August 20, 2020, 2:33 pm
---------------------------------------------------------
From PubMed (August 20, 2020)--"Progressive multifocal
leucoencephalopathy in dimethyl fumarate-treated multiple
sclerosis patients":
HTML https://pubmed.ncbi.nlm.nih.gov/32808554/
The researchers are affiliated with the Consortium of Multiple
Sclerosis Centers (CMSC) and the University of Michigan.
#Post#: 3839--------------------------------------------------
PML outcomes in MS patients treated with dimethyl fumarate
By: agate Date: November 14, 2022, 1:41 am
---------------------------------------------------------
Some Biogen researchers have published a report on MS patients
being treated with dimethyl fumarate who developed PML.
From Multiple Sclerosis Journal (November 10,
2022)--"Progressive multifocal leucoencephalopathy outcomes in
patients with multiple sclerosis treated with dimethyl
fumarate":
HTML https://journals.sagepub.com/doi/full/10.1177/20552173221132469
#Post#: 3957--------------------------------------------------
Authors' correction to the previously cited article
By: agate Date: March 8, 2023, 1:35 am
---------------------------------------------------------
The authors of the article in the previous post in this thread
have published a correction (Multiple Sclerosis Journal,
February 27, 2023):
HTML https://journals.sagepub.com/doi/full/10.1177/20552173231160312
*****************************************************